Profitability Ratios
| Ratio |
Value |
| GP Margin |
64.6% |
| EBIT Margin |
-9.7% |
| EBITDA Margin |
-9.7% |
| Operating Margin |
-12.6% |
| Pretax Margin |
-12.6% |
| Cont. Ops Margin |
-12.6% |
| Net Margin |
-12.6% |
| Bottom Line Margin |
-12.6% |
Liquidity Ratios
| Ratio |
Value |
| Current Ratio |
5.94 |
| Quick Ratio |
4.63 |
| Solvency Ratio |
-0.357 |
| Cash Ratio |
1.44 |
Valuation Ratios
| Ratio |
Value |
| Price/Earnings |
|
| PEG Ratio |
2.20 |
| Forward PEG |
2.20 |
| Price/Book |
3.10 |
| Price/Sales |
12.00 |
| Price/FCF |
108.55 |
| Price/Op Cash Flow |
57.40 |
Debt Ratios
| Ratio |
Value |
| Debt/Assets |
0.0441 |
| Debt/Equity |
0.0481 |
| Debt/Capital |
0.0459 |
| Long-Term Debt/Capital |
0.0000 |
| Financial Leverage |
1.09 |
Cash Flow Ratios
| Ratio |
Value |
| Working Capital Turnover |
0.84 |
| Operating Cash Flow Ratio |
0.875 |
| Operating Cash Flow/Sales |
20.9% |
| Free Cash Flow/Operating Cash Flow |
52.9% |
Coverage Ratios
| Ratio |
Value |
| Debt Service Coverage |
-1.22 |
| Interest Coverage |
-4.4826 |
| Short-Term Operating Cash Flow Coverage |
4.03 |
| Operating Cash Flow Coverage |
1.12 |
| Capital Expenditure Coverage |
2.12 |
| Dividend + Capital Expenditure Coverage |
2.12 |
Dividend Ratios
| Ratio |
Value |
| Payout Ratio |
0.0000% |
| Dividend Yield |
0.0000% |
| Dividend Yield % |
0.0000% |
| Dividend Per Share |
0.0000 |
Per Share Ratios
| Ratio |
Value |
| Revenue/Share |
2.01 |
| EPS |
-0.254 |
| Debt/Share |
0.4314 |
| Cash/Share |
1.86 |
| Book Value/Share |
7.79 |
| Tangible BV/Share |
3.33 |
| Equity/Share |
7.79 |
| Operating Cash Flow/Share |
0.421 |
| Capital Expenditure/Share |
0.198 |
| FCF/Share |
0.223 |
Other Ratios
| Ratio |
Value |
| Net Income/Earnings Before Tax |
1.004 |
| Earnings Before Tax/EBIT |
0.996 |
| Price/Fair Value |
3.10 |
| Debt/Market Cap |
0.0043 |
| Effective Tax Rate |
-0.4% |
| Enterprise Value Multiple |
-121.55 |
BLFS - BioLife Solutions, Inc.